This amount of Lansing virus results in a typical flaccid paralysis of one or more muscle groups in 85 -to 95 per cent of well nourished mice. Almost all paralyzed mice die within a few days of the onset of paralysis; a small number, rarely more than 5 per cent, die without exhibiting paralysis. A still smaller number, less than 2 per cent, survive without signs of experimental infection.
The experimental disease is modified in mice suffering from the various amino acid deficiencies in that a greater proportion dies without exhibiting paralysis before death. The experiments are designed so that deaths from the deficiencies should not occur within the usual incubation period; but, with the prolongation of incubation periods characteristically seen in deficient animals, some overlapping occurs. Mice were observed daily for at least 28 days following the injection of virus, and the results were recorded as typical paralysis P, or as 
0%O 0% 0% 0%0% % 0% %0% %0% 0% 0% 0% On the 12th day post inoculation, the valine and methionine deficient groups both lag behind the control groups in total paralysis as well as in total presumptive virus infection. This is more clearly shown in the calculated average incubation period. The controls show an average incubation period of 9.6 and 9.7 days. Methionine deficient animals show an average incubation period about 1 day greater; this is of questionable significance. Valine deficiency results in a prolongation of almost 3 days. The average survival time is also presented but is not considered significant because in many cases it represents an average of only 2 or 3 mice. The data obtained in series 136 indicate that valine deficiency delays the onset of symptoms and that methionine deficiency produces a similar although less marked effect.
Lysine. Throughout the entire experiment, lysine deficiency paralleled and at times surpassed the control groups in the incidence of paralysis (table 4) . The average incubation period was slightly greater in the lysine deficient group than in the control groups. The total presumptive virus infection of both lysine 574 [voL. 64 symptoms occurs, nor a decrease in incidence of infection.
Histidine, lucine, and threonine. Mice deficient in any one of these three amino acids behave similarly (table 4). Up to the 12th day post inoculation, a noticeable lag in onset of symptoms occurred, but the incidence of paralysis in all groups at the end of the experiment (28th day) was approximately the same. The average incubation period for these three deficiencies varied from 11.1 to 12.9 days. The average survival time for histidine deficiency was 9.8 days, for leucine deficiency 11.0 days, but for threonine deficiency 16.0 days. Ultimately the total presumptive infection for all 3 groups reached 100 per cent. Animals on rations deficient in histidine, leucine, or threonine show a prolonged incubation period.
Phenylalanine. Phenylalanine deficiency approximated the effectiveness of valine deficiency in reducing the incidence of paralysis. In series 136 the difference in paralysis between valine deficiency and the controls was 28 per cent to 29 per cent. In series 139 the difference in paralysis between phenylalanine deficiency and the controls was 20 per cent to 22 per cent.
Of the amino acids studied in series 136 and 139, valine and phenylalanine deficiencies are most effective in altering the course of Lansing infection in mice. The result is one of delay (ca 3 days) in onset of paralysis with the total incidence of presumptive infection remaining unchanged. Histidine, leucine, threonine, and methionine deficiencies are less effective but show a similar trend. Lysine deficiency is ineffective and, in fact, may enhance the general physiologic impact of the virus on the mice. The only favorable effect of a lysine deficiency is an increase of a day or so in the incubation period.
Isolucine. Because isoleucine-free rations result in a severe deficiency state in mice with early deaths, 0.25 per cent was added to the deficient rations used in these experiments. When fed a ration containing this amount, mice lose weight and develop a clear-cut deficiency, but almost 100 per cent of those uninoculated survive the 35 days necessary for each experiment. The data obtained using isoleucine deficient rations are presented in tables 5 and 6. The two experiments with isoleucine deficient rations are essentially in accord. In each are observed a delay in the onset of symptoms and a decreased incidence of paralysis in the deficient groups, as compared with the controls.
Series 132 was designed to determine whether the state or degree of deficiency of the mouse at the time of inoculation might have some bearing on the course of the disease. The data in table 6 clearly show that the mice may be fed isoleucine deficient AAM-2 for as little as 7 days and yet respond to Lansing virus almost identically with mice fed the same ration 13 days prior to inoculation. The average incubation period and the average survival time for the 3 groups deficient 7, 10, and 13 days before inoculation, respectively, range from 11.2 to 12.8 days (table 6), a fair degree of uniformity. Comparable uniformity also prevails with regard to incidence of paralysis, fatalities, and total virus infection.
Tryptophan. In series 121 ( by each for its existence. Experimentally we can determine by direct methods whether or not virus proliferates in amino acid deficient inoculated mice which have died without observed evidence of infection. Several preliminary studies have shown that amino acid deficient mice inoculated and then sacrificed at selected intervals post inoculation contain measurable amounts of virus in the central nervous system. Series 127 was an experiment of this type. Isoleucine and tryptophan deficient AAM-2 groups as well as AAM-2 and optimuim groups were fed the rations for 9 days, were then inoculated, and beginig 2 days after the inoculation were sacrificed at the rate of 2 mice each second day. Admittedly the selection was biased, for in picking the animals to be sacrificed, the paralyzed or the more obviously deficient mice were chosen first.
The central nervous system of each sacrificed mouse was tested (brain and cord separately) for virus activity using a fixed dilution (10-2 saline suspension). The second day specimens showed appreciable amounts of virus in the brain in all four groups. The level remained fairly high up to the 8th to 10th day, after which it declined. On approximately the 5th to 8th day, virus began to appear in the cord in significant amounts in all groups except the tryptophan deficient. The latter group had no paralyzed animals up to the 12th day. This experiment was obviously a crude one, but one fact is apparent, the virus seemingly multiplies in the brain during the first days post inoculation and then moves down the central nervous system to parasitize susceptible cells in the spinal cord.
Series 140 was conducted to obtain quantitative data relative to levels of virus reached in the brain and cord of tryptophan deficient and nondeficient mice. In series 127, brains and cords from individual animals were tested, but in series 140, pools of 5 mice were taken at random every second day post inoculation. Seventy-two mice (numbered) in each of 2 groups (tryptophan deficient based on AAM-2 and AAM-2 controls) were inoculated with Lansing virus, and the first five in each group were sacrificed the following day, pool I. On the third day post inoculation, the next 5 mice in numerical order (regardless of symptoms) were sacrificed, and so on through the series. The five brains were pooled, as were the five cords, and these were titrated for virus using 4 dilutions (1:5, 10-1, 10-2, 10) 5 mice per dilution. When possible, the inoculations were made on the same day that the tissues were obtained. When this was not possible, the animals were sacrificed and the tissue was prepared in its lowest dilution (1:5) and stored at -40 C. None of the pools was held at -40 C more than eight weeks. The AAM-2 group had fewer pools because the animals became paralyzed and died more quickly than the mice in the tryptophan deficient group. The LD50 (Reed and Muench, 1938) of each pool was calculated (where possible); we were not expecting titers much greater than 3.0 since potent virus stock has an LDr0 titer of 4.0 -0.5. In those instances in which the titer is greater than 3.0 it is probably not much greater.
The results of series 140 are presented graphically in figure 1 . A similar experiment was performed using Theiler's GDVII virus with similar results (Pond et al., 1952) . While the quantitative accuracy is not great, certain points are evident which support the earlier experiments. The days immediately following inoculation show low levels of virus in the cord (less than 1.0 LD)o) but higher levels in the brain. From about the 3rd day on, the LDro in the brain of tryptophan deficient mice varies from 2.0 to 3.0 with no tendency to rise or fall. The LD50 in the brain of the AAM-2 group, up to the 7th day, is equal to or greater than the corresponding tryptophan deficient group and decreases rather sharply to less than 1.0 by the 11th day (no pools were obtained on the 13th or 15th days Each column represents the log LD50 value for a pool of the tissues from five mice sacrificed on the indicated day.
The cord of tryptophan deficient mice contained less than 1.0 LD50 for 5 days. From the 7th day on, the LD60 varied from 2.8 to 3.0. The cord of AAM-2 mice contained 2.5 LD50 by the 3rd day, reaching a peak value by the 7th day. Trhe concentration of virus did not decrease for the remaining 4 days.
Considering the AAM-2 group, virus concentration is high in the brain during the first 24 to 48 hours post inoculation, after which time appreciable amounts of virus begin to appear in the cord. Peak levels are reached in the brain on the 3rd to 7th day whereas the peak levels in the cord were not reached until the 7th to 11th day.
In the tryptophan deficient group, a somewhat similar trend is noted, i.e.,
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peak levels in brain on approximately the 3rd day, whereas peak levels in the cord were not reached until the 7th day. In the brain, the virus concentration in the tryptophan deficient group was rather constant after the peak was reached on the 3rd day. LDs0 ranged from 2.0 to 2.8 for one week. In every instance after the 7th day, levels in the cord exceeded, or were equal to, levels in the brain in both the tryptophan deficient and the amino acid no. 2 groups. Since the increase in the length of the incubation period (also manifested by an increased survival time) was the most characteristic finding in the deficient as compared to the normal groups, the results of a representative experiment (isoleucine experiment, table 6) were tested statistically4 by the analysis of the variance between the mean incubation periods of the five experimental groups, i.e., the three isoleucine deficient groups with mean incubation periods of 12, 12, and 11.2 days, respectively, and the two control groups (AAM-2 and 19 per cent casein), with identical average incubation periods of 9 days. The results of the analysis are shown in table 8. According to the analysis there is no significant difference in incubation periods among the three deficient or between the two control groups. There were significant differences, less than a one in twenty possibility of chance differences, between any one of the three deficient groups and either of the two control groups. When the three deficient groups are classed together and compared with the two control groups, the probability of the observed difference *being due to chance was less than one in a hundred.
The differences between the incubation periods of the deficient and control mice in the other amino acid deficiencies consistently follow this same pattern although the differences were not as great in some instances and greater in others (i.e., tryptophan). It is possible that some of the differences are not statistically significant in themselves. However, when considered with the results of the other experiments, even these small differences became significant.
